Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alphagan P and Lumigan in Glaucoma and Ocular Hypertension
NCT01525173Phase 4Completed
- Sponsor
- Allergan
- Start
- Jan 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of brimonidine in Glaucoma, ocular hypertension, sponsored by Allergan. Started Jan 2012; status: completed.
02
Drugs
brimonidine
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT01525173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01525173.